Latest News

AVx's AVD system has been clinically tested in 102 patients in a variety of procedures including TURP, pacemaker insertion, amputation, total knee, plastic surgery, vascular intervention, and neurosurgery.

 

AVx Medical

454 Las Gallinas Ave.
Suite 159
San Rafael, CA 94903
U.S.A.

Contact Us
contact us

AVx Medical: Devices for patient safety & comfort

AVx Medical: Medical Electronics to Improve Safety and Comfort of Patients

Art Wallace, M.D., Ph.D., Founder and CEO

Dr. Wallace lecturing on cardiac monitoring in LondonDr. Wallace is an attending anesthesiologist at UCSF School of Medicine and the VA Medical Center in San Francisco and Professor in Residence in the Department of Anesthesia and Perioperative Care, University of California-San Francisco. Besides his clinical, academic and administrative activities, Dr. Wallace lectures internationally on changing anesthesia practice. Prior to AVx Medical, Dr. Wallace developed a new class of device to measure cardiac output- the Endotracheal Cardiac Output Computer (ECOM) which has been patented and has received FDA 510(k) clearance. ECOM is currently being marketed by ConMed.

Dr. Wallace holds a Bachelor of Science in Engineering and Applied Science from Yale University, and an M.D. and Ph.D. in Biomedical Engineering from Johns Hopkins Medical School. He served his internship and residency in anesthesiology at the University of California, San Francisco and obtained his fellowship in Cardiac Anesthesia from the same institution.

Dr. Wallace created and managed an Ambulatory Surgery Program that treats 3000 patients per year. The program resulted in shorter length of stays and $12 million per year in cost savings. Dr. Wallace also established a pre-op clinic, managed nurse practitioners and the day-to-day operation of the clinic for 5 years. Dr. Wallace has been successful in changing management practice within hospitals. He changed the surgical behavior in VA hospitals (from 100% inpatients to 90% outpatients). Dr. Wallace also changed cardiology practice by identifying and proving the benefit of widespread use of Beta blockers and clonidine. It has been shown to be so beneficial that beta blocker/clonidine care is one of the seven protocols recommended by the AHA and ACC. Dr. Wallace promoted this practice by changing the mindset of hospital management in 10 different hospitals nationwide. This beta blocker/clonidine care change can result in cost savings of $12bn annually in evaluation cost, $40bn in operative cost and $500m in preventing death.

Dr. Wallace's most recent research includes surgical treatment of congestive heart failure which clinical results have been published in Circulation, study of endothelial function to prevent myocardial injury during CABG surgery; developing off-pump mitral valve repair devices, off-pump CABG devices, a device to reduce the incidence of hypotensive events, and a non-invasive device to detect hypercapnia. Dr. Wallace is named in 4 patents issued and has published over 60 different scientific papers. He received the B.B Sankey Award, REAC Award-University of California, San Francisco, Foundation for Anesthesia Education and Research Young Investigator Award.

Dr. Wallace is a member of California Society of Anesthesiologists, American Society of Anesthesiologists, Society of Cardiovascular Anesthesiology, International Anesthesia Research Society, Multi-centered Study of Perioperative Ischemia (McSPI). Dr Wallace is also member of editorial review for the journal Anesthesiology, Anesthesia Analgesia and Annals of Thoracic Surgery.

For more see Art Wallace's home page.


About AVx Medical

 
 
Our Policy

AVx Medical develops effective, low-cost, low-risk sedation devices that minimize anesthesiologist time in medical procedures, increase patient throughput in hospitals, and reduce medical risk and cost for outpatient medical procedures.

 

 

home | instructions | products | newsletter | about us | contact us


Copyright 2004 - 2015 AVx Medical, All Rights Reserved